Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vimentin-ERK Signaling Uncouples Slug Gene Regulatory Function.
Virtakoivu R, Mai A, Mattila E, De Franceschi N, Imanishi SY, Corthals G, Kaukonen R, Saari M, Cheng F, Torvaldson E, Kosma VM, Mannermaa A, Muharram G, Gilles C, Eriksson J, Soini Y, Lorens JB, Ivaska J. Virtakoivu R, et al. Cancer Res. 2015 Jun 1;75(11):2349-62. doi: 10.1158/0008-5472.CAN-14-2842. Epub 2015 Apr 8. Cancer Res. 2015. PMID: 25855378
SHARPIN regulates collagen architecture and ductal outgrowth in the developing mouse mammary gland.
Peuhu E, Kaukonen R, Lerche M, Saari M, Guzmán C, Rantakari P, De Franceschi N, Wärri A, Georgiadou M, Jacquemet G, Mattila E, Virtakoivu R, Liu Y, Attieh Y, Silva KA, Betz T, Sundberg JP, Salmi M, Deugnier MA, Eliceiri KW, Ivaska J. Peuhu E, et al. Among authors: virtakoivu r. EMBO J. 2017 Jan 17;36(2):165-182. doi: 10.15252/embj.201694387. Epub 2016 Dec 14. EMBO J. 2017. PMID: 27974362 Free PMC article.
Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial.
Virtakoivu R, Rannikko JH, Viitala M, Vaura F, Takeda A, Lönnberg T, Koivunen J, Jaakkola P, Pasanen A, Shetty S, de Jonge MJA, Robbrecht D, Ma YT, Skyttä T, Minchom A, Jalkanen S, Karvonen MK, Mandelin J, Bono P, Hollmén M. Virtakoivu R, et al. Clin Cancer Res. 2021 Aug 1;27(15):4205-4220. doi: 10.1158/1078-0432.CCR-20-4862. Epub 2021 Jun 2. Clin Cancer Res. 2021. PMID: 34078651 Free PMC article. Clinical Trial.
Clever-1 positive macrophages in breast cancer.
Mutka M, Virtakoivu R, Joensuu K, Hollmén M, Heikkilä P. Mutka M, et al. Among authors: virtakoivu r. Breast Cancer Res Treat. 2022 Oct;195(3):237-248. doi: 10.1007/s10549-022-06683-4. Epub 2022 Aug 2. Breast Cancer Res Treat. 2022. PMID: 35917053 Free PMC article.
Enhanced Antibody Production in Clever-1/Stabilin-1-Deficient Mice.
Dunkel J, Viitala M, Karikoski M, Rantakari P, Virtakoivu R, Elima K, Hollmén M, Jalkanen S, Salmi M. Dunkel J, et al. Among authors: virtakoivu r. Front Immunol. 2018 Oct 8;9:2257. doi: 10.3389/fimmu.2018.02257. eCollection 2018. Front Immunol. 2018. PMID: 30349531 Free PMC article.
Clever-1 contributes to lymphocyte entry into the spleen via the red pulp.
Tadayon S, Dunkel J, Takeda A, Halle O, Karikoski M, Gerke H, Rantakari P, Virtakoivu R, Pabst O, Salmi M, Hollmén M, Jalkanen S. Tadayon S, et al. Among authors: virtakoivu r. Sci Immunol. 2019 Mar 29;4(33):eaat0297. doi: 10.1126/sciimmunol.aat0297. Sci Immunol. 2019. PMID: 30926591
12 results